Healthcare

The UAE becomes a test bed for medical AI

UAE institutions are moving medical AI into clinical settings, including pathology, fetal imaging, autism screening, and heart-failure detection.

A Fast Company Middle East report described the UAE as a test bed for medical AI moving from research settings into clinical care. Examples included systems intended to support earlier disease detection, faster diagnosis, and more precise treatment. UAE studies cited in the article examined AI applications for early autism flagging, fetal-scan abnormalities, and early signs of heart failure. In Abu Dhabi, M42’s National Reference Laboratory is working with Qritive on an AI-powered prostate-cancer pathology tool. The system analyzes digitized tissue samples and flags suspicious areas for closer review by pathologists. This is relevant because pathology traditionally relies on manual microscope examination of biopsy samples. The article emphasizes that the main challenge is evaluating medical AI after pilot projects, including how reliably it performs in routine clinical environments.

Original source: Fast Company Middle East

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI